logo
Scientist In Mexico Develops Tortillas For People With No Fridge

Scientist In Mexico Develops Tortillas For People With No Fridge

NDTV15-05-2025

Peering through a microscope, food scientist Raquel Gomez studies microorganisms that add nutrients and preserve tortillas for several weeks without refrigerators -- a luxury in impoverished Mexican communities.
The humble tortilla is a Mexican staple, consumed in tacos and other dishes by millions every day, from the Latin American nation's arid northern deserts to its tropical southern jungle.
Most Mexicans buy fresh corn tortillas from small neighborhood shops.
The wheat flour version developed by Gomez and her team contains probiotics -- live microorganisms found in yogurt and other fermented foods.
Along with the nutritional benefits, the fermented ingredients mean the tortilla can be kept for up to a month without refrigeration, much longer than a homemade one, according to its creators.
It was developed "with the most vulnerable people in mind," Gomez, a professor at the National Autonomous University of Mexico (UNAM), told AFP in her laboratory.
Nearly 14 percent of children under five suffer from chronic malnutrition in Mexico, according to official figures.
In Indigenous communities, the figure is around 27 percent.
Fridges unaffordable
The tortilla developed by Gomez is not yet commercially available, but it could benefit people like Teresa Sanchez.
Sanchez, a 46-year-old housewife, smokes meat using a wood-burning stove in her house with wooden walls and a metal roof.
Like most of her neighbors in the town of Oxchuc, in the southern state of Chiapas, Sanchez has no refrigerator, so she uses the methods handed down by her Indigenous Tzeltal ancestors.
"My mother taught me and grandparents always do it this way," she told AFP.
"Where are you going to get a refrigerator if there's no money?"
Less than two-thirds of people in Chiapas, a poverty-plagued region with a large Indigenous population, have a refrigerator -- the lowest level among Mexico's 32 states.
The average maximum temperature in Chiapas rose from 30.1 to 32 degrees Celsius (90 Fahrenheit) between 2014 and 2024, according to official estimates.
Half of its territory is considered vulnerable to climate change.
While Oxchuc is located in a mountainous, temperate area, the lack of refrigerators forces its inhabitants to rely on traditional food preservation methods.
"We think about what we're going to eat and how many of us there are. We boil it, and if there's some left over, we boil it again," Sanchez said.
Sometimes meat is salted and left to dry under the sun.
Tortillas are stored in containers made from tree bark.
For that reason, Sanchez shops only for the bare necessities, though her budget is limited anyway.
"I don't have that much money to buy things," she said.
No preservatives
Gomez and her team use prebiotics -- which are mainly found in high-fiber foods -- to feed probiotic cultures and produce compounds beneficial to health, she said.
Thanks to the fermented ingredients, no artificial preservatives are needed in the laboratory developed tortilla, Gomez said.
That is another benefit because such additives have potentially toxic effects, said Guillermo Arteaga, a researcher at the University of Sonora.
One of the most commonly used additives in processed wheat flour tortillas is calcium propionate, which is considered harmful to the colon's microbiota, Arteaga said.
Although her tortilla is made from wheat flour -- a type eaten mainly in northern Mexico -- Gomez does not rule out using the same method for corn tortillas, which are preferred by many Mexicans but can go bad quickly in high temperatures.
The researchers patented their tortilla in 2023. UNAM signed a contract with a company to market the food, but the agreement fell through.
Gomez, who won an award in December from the Mexican Institute of Industrial Property, still hopes to find partners to distribute her tortillas.
She is confident that even though they were developed in a laboratory, consumers will still want to eat them.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Plane crashes near southern Mexico amid screwworm control efforts, 3 dead
Plane crashes near southern Mexico amid screwworm control efforts, 3 dead

Hindustan Times

time6 hours ago

  • Hindustan Times

Plane crashes near southern Mexico amid screwworm control efforts, 3 dead

Two Guatemalan pilots and a Mexican agronomist engineer died Friday when their plane crashed in southern Mexico near the border with Guatemala as they freed sterile flies meant to stop the spread of screwworm in cattle. Mexico's Agriculture Ministry said in a statement that the Guatemalan plane crashed near Tapachula in southern Mexico, but did not give a cause. Mexico had stepped up efforts to control the spread of the pest last month under pressure from the United States government, which suspended cattle imports from Mexico because of fear of the screwworm. President Claudia Sheinbaum had said Friday that she didn't know when the suspension would be lifted, but that specialists from the US were in Mexico studying the country's efforts. The screwworm is a larva of the Cochliomyia hominivorax fly that can invade the tissues of any warm-blooded animal, including humans. The parasite enters animals' skin, causing severe damage and lesions that can be fatal. (AP) PY PY

How Google reviews helped US couple to win $2 million 'bed bug lawsuit' against hotel
How Google reviews helped US couple to win $2 million 'bed bug lawsuit' against hotel

Time of India

time20 hours ago

  • Time of India

How Google reviews helped US couple to win $2 million 'bed bug lawsuit' against hotel

Representative Image A California couple has won a $2 million award in a " bed bug lawsuit " against The Shores Inn in Ventura, California. The couple was able to win this lawsuit after Google and Yelp reviews helped to establish the hotel's prior knowledge of the infestation. Alvaro Gutierrez and Ramiro Sanchez filed the lawsuit following a February 2020 stay at the hotel, which they claimed left them with "painful bed bug bites, severe skin rash, allergic reaction, scarring and personal injuries over the entirety of their bodies," according to the complaint obtained by USA Today. The lawsuit, filed in December 2021 by lawyer Brian J. Virag, alleged that after discovering the bedbug infestation in their initial room, the couple was moved to another, where they "continued to be massacred from bed bugs (sic) bites." Moreover, the complaint also alleged, based on Google and Yelp reviews left by previous guests, that the hotel management had been informed of the same bed bug issue before their stay. How the visit to the California hotel affected the couple Gutierrez and Sanchez sought medical treatment following their stay at the hotel, the lawsuit claims, as bed bugs "latched onto the plaintiffs while they slept, sucked their blood until they were gorged, and resisted eradication." According to the complaint, the two suffered pain, illness, and emotional and mental distress due to the incident. As a result, they checked out of the hotel after just one night, despite having booked a week-long stay, the lawsuit states. Last month, jurors awarded Gutierrez $400,000 for pain, disfigurement, grief, and emotional distress, while Sanchez received $600,000 for similar complaints. Additionally, both men were awarded $500,000 each in punitive damages . The hotel plans to appeal or otherwise contest the ruling, appellant lawyer Wendy Lascher told the Los Angeles Times. Following the verdict, a note was discovered in one juror's notebook suggesting that two jurors may have visited the inn during the trial, and another juror reportedly remarked to others during the proceedings that the hotel was 'an eyesore and should be torn down," LA Times reported. JBL Tune Beam 2 Review: The TWS Earbuds That Punch Above Their Weight!

New hope for patients with less common breast cancer
New hope for patients with less common breast cancer

The Hindu

timea day ago

  • The Hindu

New hope for patients with less common breast cancer

Results from the study, presented at the annual meeting of the American Society for Clinical Oncology, are expected to be submitted to regulators and could soon establish a new first-line therapy for people with HER2-positive metastatic breast cancer -- the advanced stage of a form that comprises 15-20 percent of all breast cancer cases. HER2-positive cancers are fueled by an overactive HER2 gene, which makes too much of a protein called human epidermal growth factor receptor 2 that helps cancer cells grow and spread. Patients with HER2-positive breast cancer that has spread to other parts of the body live around five years. "Seeing such a striking improvement was really impressive to us -- we were taking a standard and almost doubling how long patients could have their cancer controlled for," oncologist Sara Tolaney, chief of the breast oncology division at Dana-Farber Cancer Institute, told AFP. The current standard of care, known as THP, combines chemotherapy with two antibodies that block growth signals from the HER2 protein. The new approach uses a drug called trastuzumab deruxtecan (T-DXd), an antibody attached to a chemotherapy drug. Smart bomb This "smart bomb" strategy allows the drug to target cancer cells directly. "You can bind to the cancer cell and dump all that chemo right into the cancer cells," explained Tolaney. "Some people call them smart bombs because they're delivering chemo in a targeted fashion -- which is how I think we're able to really increase efficacy so much." Common side effects included nausea, diarrhea and a low white blood cell count, with a less common effect involving lung scarring. T-DXd is already approved as a "second-line" option -- used when first-line treatments stop working. But in the new trial, it was given earlier, paired with another antibody, pertuzumab. In a global trial led by Tolaney, just under 400 patients were randomly assigned to receive T-DXd in combination with pertuzumab, thought to enhance its effects. A similar number received the standard THP regimen. A third group, who received T-DXd without pertuzumab, was also enrolled -- but those results haven't yet been reported. 44 percent risk reduction At a follow-up of 2.5 years, the T-DXd and pertuzumab combination reduced the risk of disease progression or death by 44 percent compared to standard care. Fifteen percent of patients in the T-DXd group saw their cancer disappear entirely, compared to 8.5 percent in the THP group. Because this was an interim analysis, the median progression-free survival -- meaning the point at which half the patients had seen their cancer return or worsen -- was 40.7 months with the new treatment, compared to 26.9 months with the standard, and could rise further as more data come in. Tolaney said the results would be submitted to regulators around the world, including the US Food and Drug Administration, and that future work would focus on optimising how long patients remain on the treatment, particularly those showing complete remission. "This represents a new first-line standard treatment option for HER2-positive metastatic breast cancer," said Rebecca Dent, a breast cancer specialist at the National Cancer Center Singapore who was not involved in the study

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store